Dr. Kalle Gehring's Article "High-Throughput Screening for Ligands of the HEPN Domain of Sacsin" published in the PLOS (Public Library of Science) in the September edition. Dr. Kalle Gehring is a member of the ARSACS research team. PLOS is a non-profit publisher and advocacy organisation funded to accelerate progress in science and medicine.
The ARSACS project entitled "PREPARE" and led by Dr. Matthis Synofzik (Germany) has been selected for funding as part of the international competition E-Rare-3 European Research Projects on Rare Diseases. A total of 234 projects were submitted last February and 19 were retained. The "PREPARE" project involves a consortium of ARSACS researchers from several countries (Canada, Germany, Netherlands, France, Italy and Turkey). Congratulations to Dr. Synofzik, Dr. Bernard Brais and to the consortium partners for this success!
The Foundation is pleased to announce that eleven research projects have been selected to share over $1.4M in research grants for its 2015-2016 research program. All applications received were evaluated by the Scientific Committee. The Foundation would like to thank all candidates who submitted a proposal.Read More
On June 23, a meeting was held in Montreal between a pharmaceutical company and the ARSACS research team with respect to the outcome of the preclinical trial phase 11 currently underway on the ARSACS mice at the Douglas Institute. The complete results should be known in November 2015. See Meeting Summary.